CL2014002033A1 - Compuestos derivados de dihidrofurano-azetidina y sus sales; composicion farmaceutica o veterinaria que los comprende; y su uso para tratar una infeccion o infestacion parasitaria. - Google Patents
Compuestos derivados de dihidrofurano-azetidina y sus sales; composicion farmaceutica o veterinaria que los comprende; y su uso para tratar una infeccion o infestacion parasitaria.Info
- Publication number
- CL2014002033A1 CL2014002033A1 CL2014002033A CL2014002033A CL2014002033A1 CL 2014002033 A1 CL2014002033 A1 CL 2014002033A1 CL 2014002033 A CL2014002033 A CL 2014002033A CL 2014002033 A CL2014002033 A CL 2014002033A CL 2014002033 A1 CL2014002033 A1 CL 2014002033A1
- Authority
- CL
- Chile
- Prior art keywords
- dihydrofuran
- infestation
- azetidine
- treat
- pharmaceutical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261594569P | 2012-02-03 | 2012-02-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2014002033A1 true CL2014002033A1 (es) | 2014-10-03 |
Family
ID=47679106
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2014002033A CL2014002033A1 (es) | 2012-02-03 | 2014-07-30 | Compuestos derivados de dihidrofurano-azetidina y sus sales; composicion farmaceutica o veterinaria que los comprende; y su uso para tratar una infeccion o infestacion parasitaria. |
Country Status (14)
Country | Link |
---|---|
US (1) | US9133172B2 (es) |
EP (1) | EP2814825B1 (es) |
JP (1) | JP5997779B2 (es) |
CN (1) | CN104169273B (es) |
AR (1) | AR092792A1 (es) |
AU (1) | AU2013215368A1 (es) |
BR (1) | BR112014018650A8 (es) |
CA (1) | CA2863625C (es) |
CL (1) | CL2014002033A1 (es) |
ES (1) | ES2571444T3 (es) |
MX (1) | MX336430B (es) |
PL (1) | PL2814825T3 (es) |
RU (1) | RU2014131951A (es) |
WO (1) | WO2013116230A1 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6049866B2 (ja) * | 2012-05-09 | 2016-12-21 | ゾエティス・サービシーズ・エルエルシー | 駆虫剤としてのアゼチジン誘導体 |
CA2881844A1 (en) * | 2012-09-07 | 2014-03-13 | Zoetis Llc | Spirocyclic derivatives as antiparasitic agents |
MX370163B (es) * | 2015-01-16 | 2019-12-04 | Avista Pharma Solutions Inc | Compuestos antiparasitarios. |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW524667B (en) | 1996-12-05 | 2003-03-21 | Pfizer | Parasiticidal pyrazoles |
JP2007501781A (ja) * | 2003-08-07 | 2007-02-01 | ファルマシア・アンド・アップジョン・カンパニー・エルエルシー | 駆虫及び殺虫ピリミジン誘導体 |
GB0329314D0 (en) | 2003-12-18 | 2004-01-21 | Pfizer Ltd | Substituted arylpyrazoles |
TW200538433A (en) * | 2004-02-24 | 2005-12-01 | Irm Llc | Immunosuppressant compounds and compositiions |
TW200803740A (en) * | 2005-12-16 | 2008-01-16 | Du Pont | 5-aryl isoxazolines for controlling invertebrate pests |
CN101331127B (zh) * | 2005-12-16 | 2012-05-23 | 杜邦公司 | 用于防治无脊椎害虫的5-芳基异噁唑啉 |
DE602007006288D1 (de) | 2006-03-10 | 2010-06-17 | Nissan Chemical Ind Ltd | Substituierte isoxazolin-verbindung und schädlingsbekämpfungsmittel |
WO2008122375A2 (en) * | 2007-04-10 | 2008-10-16 | Bayer Cropscience Ag | Insecticidal aryl isoxazoline derivatives |
KR20100064382A (ko) | 2007-09-10 | 2010-06-14 | 닛산 가가쿠 고교 가부시키 가이샤 | 치환 이속사졸린 화합물 및 유해생물 방제제 |
CN102131804B (zh) * | 2008-08-22 | 2014-12-03 | 先正达参股股份有限公司 | 杀虫化合物 |
JP2013520403A (ja) * | 2010-02-22 | 2013-06-06 | シンジェンタ パーティシペーションズ アクチェンゲゼルシャフト | 殺虫化合物としてのジヒドロフラン誘導体 |
BR112013002871B1 (pt) * | 2010-08-05 | 2018-11-21 | Zoetis Llc | derivados de isoxazolina, seu uso e composição farmacêutica ou veterinária |
-
2013
- 2013-01-29 RU RU2014131951A patent/RU2014131951A/ru not_active Application Discontinuation
- 2013-01-29 PL PL13703286T patent/PL2814825T3/pl unknown
- 2013-01-29 MX MX2014009387A patent/MX336430B/es unknown
- 2013-01-29 BR BR112014018650A patent/BR112014018650A8/pt not_active IP Right Cessation
- 2013-01-29 AU AU2013215368A patent/AU2013215368A1/en not_active Abandoned
- 2013-01-29 JP JP2014555625A patent/JP5997779B2/ja not_active Expired - Fee Related
- 2013-01-29 ES ES13703286T patent/ES2571444T3/es active Active
- 2013-01-29 US US14/375,061 patent/US9133172B2/en not_active Expired - Fee Related
- 2013-01-29 CA CA2863625A patent/CA2863625C/en not_active Expired - Fee Related
- 2013-01-29 WO PCT/US2013/023662 patent/WO2013116230A1/en active Application Filing
- 2013-01-29 CN CN201380014259.5A patent/CN104169273B/zh not_active Expired - Fee Related
- 2013-01-29 EP EP13703286.8A patent/EP2814825B1/en not_active Not-in-force
- 2013-02-01 AR ARP130100320A patent/AR092792A1/es unknown
-
2014
- 2014-07-30 CL CL2014002033A patent/CL2014002033A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
JP5997779B2 (ja) | 2016-09-28 |
AR092792A1 (es) | 2015-05-06 |
RU2014131951A (ru) | 2016-03-27 |
PL2814825T3 (pl) | 2016-08-31 |
WO2013116230A1 (en) | 2013-08-08 |
CN104169273B (zh) | 2016-11-02 |
AU2013215368A1 (en) | 2014-08-21 |
BR112014018650A2 (es) | 2017-06-20 |
ES2571444T3 (es) | 2016-05-25 |
BR112014018650A8 (pt) | 2017-07-11 |
JP2015511233A (ja) | 2015-04-16 |
US9133172B2 (en) | 2015-09-15 |
CA2863625A1 (en) | 2013-08-08 |
CN104169273A (zh) | 2014-11-26 |
MX336430B (es) | 2016-01-18 |
EP2814825A1 (en) | 2014-12-24 |
EP2814825B1 (en) | 2016-03-23 |
MX2014009387A (es) | 2014-08-27 |
CA2863625C (en) | 2016-04-26 |
US20150038440A1 (en) | 2015-02-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SMT201700052B (it) | 2-(azaindol-2-il)benzimidazoli come inibitori di pad4 | |
CL2014003136A1 (es) | Nuevos diazaespirocicloalcanos y azaespirocicloalcanos; composicion farmaceutica que los contiene y usos. | |
CL2015000295A1 (es) | Compuestos derivados de alquilpirimidina; composicion farmaceutica que los comprende; uso para el tratamiento de infecciones víricas y otras enfermedades. | |
PE20151067A1 (es) | Inhibidores de autotaxina | |
BR112016005262A2 (pt) | Compostos aril éteres, uso dos mesmos e composição farmacêutica que os compreende | |
BR112016000489A2 (pt) | composto, composição farmacêutica que o compreende, uso da composição e métodos para fabricar compostos | |
DK2841429T3 (da) | Tetrazolinonforbindelser og anvendelse deraf som pesticider | |
CL2013001947A1 (es) | Composicion farmaceutica que comprende pioglitazona; uso de pioglitazona para tratar alzheimer; composicion que comprende pioglitazona. | |
UY35467A (es) | Compuestos orgánicos | |
BR112015001596A2 (pt) | composição para o tratamento de hiperlipidemia que compreende oxintomodulina. | |
CL2014003472A1 (es) | Pro-farmacos derivados de (e)-n-metil-n-((3-metilbenzofuran-2-il)metil)-3-(7-oxo-5,6,7,8-tetrahidro-1,8-naftiridin-3-il)acrilamida; composicion farmaceutica que los comprende; y su uso para tratar una infeccion bacteriana. | |
BR112015023417A2 (pt) | compostos heterocíclicos e seus usos | |
CO6940429A2 (es) | Compuestos heterocíclicos, medicamentos que los contienen, uso de aquellos y procesos para su preparación | |
BR112016025659A2 (pt) | compostos, seus usos, e composições farmacêuticas para induzir condrogênese | |
CL2014000490A1 (es) | Compuestos derivados de pirazol y sus sales, con actividad inhibidora de sglt1; composicion farmaceutica que los comprende; y su uso para tratar o prevenir diabetes. | |
CO6852077A2 (es) | Composiciónes que comprenden ditiínas sustituidas fungicidas y compuestos activos adicionales | |
BR112015002824A2 (pt) | composto, uso de um composto, composição farmacêutica, e, produto farmacêutico de combinação. | |
CR20140263A (es) | Composicion herbicida que contiene acido de 4-amino-3-cloro-6-(-4-cloro-2-fluor-3-metoxifenil) piridina-2-carboxilico, o los derivados del mismo y fluroxipir, o los derivados del mismo | |
CL2014000393A1 (es) | Compuestos derivados de benzofurano y sus sales, como inhibidores del virus de hepatitis c; composicion farmaceutica que los comprende; y su uso para el tratamiento o la prevencion de una infeccion por el virus de hepatitis c o de una enfermedad asociada con dicha infeccion. | |
DK3258938T3 (da) | Phenothiazinanaloger som mitokondrie terapeutiske midler | |
CL2014001862A1 (es) | Compuestos derivados de morofolinilo sustituido, útiles como inhibidores de mogat-2; composicion farmaceutica que los comprende; uso en el tratamiento de hipertrigliceridemia. | |
CO7010828A2 (es) | Preparación farmacéutica que comprende ßciclodextrina sustituida | |
CL2014002951A1 (es) | (r)-nifuratel; formulacion farmaceutica que lo contiene; y proceso para fabricar (r)-nifuratel y (s)-nifuratel. | |
CL2014003495A1 (es) | Agentes herbicidas que contienen flufenacet. | |
CR20180089A (es) | Compuestos útiles para inhibir a ror-gamma-t |